Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

New study examines the use of anticholinergic drug trihexyphenidyl for PTSD symptoms

Staff Writer
Staff Writer 12 months ago
Updated 2021/07/07 at 1:46 AM
Share
SHARE

A new study in Brain and Behavior provides a first glimpse at a potentially effective anticholinergic drug known as trihexyphenidyl (TP) for the treatment of symptoms of post-traumatic stress disorder (PTSD).

According to researchers with the Sogo PTSD Institute and the Medical Corporation Sogokai, trihexyphenidyl may be effective for reducing PTSD-related flashbacks and nightmares.

As part of the study, 34 patients diagnosed with PTSD were administered the anticholinergic drug, with the vast majority, or 88 percent of patients have experienced mild to no PTSD-based nightmares; while 79 percent experienced similar responses for flashbacks.

The anticholinergic effects reported had a rapid onset, with purported improvements in mild symptoms of nightmares and flashbacks associated with PTSD.

“This study is the first to demonstrate the potential efficacy of TP in the treatment of refractory PTSD-related nightmares and flashbacks,” the co-authors detailed in their journal report.

“Further double-blind, randomized control trials are needed to explore the potential clinical benefits of TP in PTSD.”

You Might Also Like

Study finds mental distress affects almost half of all teenage females in Norway

ICD-11 lists complex post-traumatic stress disorder as a new condition

New research identifies personality traits linked to cognitive deficits

Many known biological pathways in the brain are impacted by Alzheimer’s disease

Immune system and CNS may play a major role in ALS

TAGGED: mental health, trihexyphenidyl, ptsd
Staff Writer July 6, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Tetrahydrocannabinol exposure during gestational period may affect response to fluoxetine
Next Article How air pollutants may raise the risk of menstrual cramps in women

Recommended

Clinical

Study finds mental distress affects almost half of all teenage females in Norway

1 Min Read
Clinical

ICD-11 lists complex post-traumatic stress disorder as a new condition

1 Min Read
Clinical

New research identifies personality traits linked to cognitive deficits

1 Min Read
Clinical

Many known biological pathways in the brain are impacted by Alzheimer’s disease

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?